HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Margaret Burroughs Selected Research
Margaret Burroughs Research Topics
Disease
17
Infections
11/2023 - 03/2011
16
Fibrosis (Cirrhosis)
12/2022 - 05/2009
11
Chronic Hepatitis C
04/2024 - 02/2011
5
Hepatitis C
04/2022 - 05/2009
2
Virus Diseases (Viral Diseases)
04/2024 - 01/2020
2
Liver Diseases (Liver Disease)
12/2022 - 01/2021
2
Portal Hypertension
04/2022 - 06/2011
2
Anemia
01/2017 - 03/2011
1
Intraabdominal Infections
11/2023
1
Healthcare-Associated Pneumonia
11/2023
1
Pyelonephritis
11/2023
1
Urinary Tract Infections (Urinary Tract Infection)
11/2023
1
Ventilator-Associated Pneumonia
11/2023
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1
Nasopharyngitis
01/2017
1
Dysgeusia (Parageusia)
05/2014
1
Hepatitis
07/2013
1
Hepatocellular Carcinoma (Hepatoma)
06/2011
1
Varicose Veins (Varicose Vein)
06/2011
1
Disease Progression
06/2011
1
Persistent Infection
03/2011
Drug/Important Bio-Agent (IBA)
15
glecaprevir and pibrentasvir
IBA
04/2024 - 01/2018
10
Ribavirin (Virazole)
FDA Link
Generic
01/2020 - 05/2009
6
Antiviral Agents (Antivirals)
IBA
12/2022 - 07/2013
6
peginterferon alfa-2b (Pegintron)
FDA Link
05/2014 - 05/2009
5
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
05/2014 - 03/2011
4
Protease Inhibitors (Protease Inhibitor)
IBA
12/2022 - 07/2013
4
Interferons
IBA
01/2020 - 06/2011
4
P-300
IBA
08/2019 - 01/2018
4
paritaprevir
IBA
04/2018 - 10/2015
4
ombitasvir
IBA
04/2018 - 10/2015
3
glecaprevir
IBA
01/2020 - 01/2018
3
pibrentasvir
IBA
01/2020 - 01/2018
3
Ritonavir (Norvir)
FDA Link
04/2018 - 10/2015
3
Interferon-alpha (Interferon Alfa)
IBA
06/2011 - 05/2009
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 07/2013
2
RNA (Ribonucleic Acid)
IBA
10/2015 - 05/2009
1
carbapenemase
IBA
11/2023
1
Serine (L-Serine)
FDA Link
11/2023
1
ceftazidime drug combination avibactam
IBA
11/2023
1
Tablets
IBA
01/2020
1
Bilirubin
IBA
01/2017
1
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
09/2013
1
Peptide Hydrolases (Proteases)
FDA Link
07/2013
1
Erythropoietin
FDA Link
03/2011
Therapy/Procedure
7
Therapeutics
04/2022 - 05/2009
2
Retreatment
03/2013 - 03/2011
1
Duration of Therapy
01/2018